ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2669

Systemic Lupus Erythematosus and Lactation: Factors Affecting Infant Feeding Choices in Women with SLE

Sara Wasserman1 and Megan E. B. Clowse2, 1Duke University Medical Center, Durham, NC, 2Rheumatology, Duke University Medical Center, Durham, NC

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: pregnancy and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Epidemiology, Women's Health, Cardiovascular and CNS

Session Type: Abstract Submissions (ACR)

Background/Purpose: Breastfeeding has been shown to improve maternal and infant wellbeing and long-term health, but it is currently unknown how often it is pursued in the SLE population.  We sought to determine the rate of breastfeeding and factors that promote or discourage this in the postpartum period for women with SLE.

Methods: Lupus patients enrolled in a prospective pregnancy registry completed questionnaires about infant feeding intentions at enrollment and infant feeding practices post-partum.  Throughout the pregnancy and postpartum, medications and disease activity were evaluated using the SLE pregnancy disease activity index (SLEPDAI). 

Results: 86 pregnancies occurred in women who met the 2012 SLICC criteria for SLE.  Of these, 13 resulted in a miscarriage or termination and 10 were lost to follow-up; postpartum feeding data is available for 51 pregnancies. 28 (54.9%) of pregnancies were in Caucasian women, 20 (39.2%) in African-American and 3 (5.9%) in Asian women.  The average maternal age was 29.8yrs (SD 4.8), with a range from 21.5 to 42.2yrs.  At study entry, 53 (64.6%) planned on breastfeeding, 19 (23.2%) planned on using formula, and 10 (12.2%) had no feeding plan. 

By 6 weeks postpartum, 26 (51.0%) were formula feeding exclusively and 25 (49.0%) were breastfeeding.  Of the women breastfeeding, 7 (28%) were supplementing with formula.   Compared to women who formula fed only, those who were breastfeeding were older and had less disease activity post-partum (see table).  Breastfeeding mothers also had deliveries that were more likely to be at term and their infants were less likely to have spent time in the intensive care unit.

African-American women were more likely to plan to use formula (45.0% AA vs 22.2% Caucasian, p=0.12) and to only use formula (65.0% AA vs 42.9% Caucasian, p=0.15).  African-American women were also more likely to have high SLE activity post-partum (47.4% AA vs 15.6% Caucasian, p=0.04).  In multivariate logistic regression, post-partum SLE activity (p=0.02) and whether breastfeeding was planned in pregnancy (p=0.03), but not race (p=0.6), predicted breastfeeding.

The key reasons that women breastfed included to keep the baby healthy (91.7%), to bond with the baby (66.7%), to keep infant feeding costs low (66.7%), to lose weight (58.3%), and for convenience (33%).  The main reasons that women did not breastfeed were concern over medication effects on the infant (36%); 7 (27%) of the non-breastfeeding women were taking contraindicated medications (methotrexate, mycophenolate, or azathioprine) post-partum. 

Conclusion: About half of women with lupus breastfeed for at least 6 weeks.  Factors that influence this decision include pre-delivery intention to breastfeed, maternal age, SLE activity, and medications.  Given the myriad of maternal and infant benefits seen with breastfeeding, finding approaches that facilitate this choice for women with SLE is an important goal.   

 

 

Breastfeeding

Formula Only

p-value

Number of pregnancies

25

26

 

Maternal age

31.3 (SD 4.6)

28.4 (SD 4.7)

0.027

Maternal race

    Caucasian

    African-American

16 (69.6%)

7 (30.4%)

12 (48%)

13 (52%)

0.154

SLEPDAI post-partum average (SD)

2.7 (2.9)

5.5 (4.8)

0.03

SLEPDAI post-partum >4 (high SLE activity)

3 (15%)

10 (47%)

0.04

Preterm birth

3 (12%)

10 (38.5%)

0.05

Gestational Age at Delivery

38.1 (1.6)

37.1 (2.1)

0.05

C-section

11 (44%)

10 (38.5%)

0.9

Baby stayed in the intensive care unit

4 (16%)

8 (33%)

0.2

Pre-delivery Infant Feeding Plan

   Breastfeeding

   Formula only

   No plan

 21 (87.5%)

  1 (4.2%)

  2 (8.3%)

 13 (50%)

  7 (26.9%)

  6 (23.1%)

0.016

 


Disclosure:

S. Wasserman,
None;

M. E. B. Clowse,

UCB Pharma,

5.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/systemic-lupus-erythematosus-and-lactation-factors-affecting-infant-feeding-choices-in-women-with-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology